Home » Avanir Pharmaceuticals Completes Sale Of FazaClo
Avanir Pharmaceuticals Completes Sale Of FazaClo
Avanir Pharmaceuticals announced that it has completed the sale of currently marketed, antipsychotic drug FazaClo (clozapine, USP) to Azur Pharma, a specialty pharmaceutical company headquartered in Ireland.
Avanir
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May